Then, thyroid cancer patients undergoing blood tests (such as TSH, T3, free T4, anti-thyroglobulin, calcitonin, and thyroglobulin) for diagnosis or follow-up examinations could undergo the developed cytokine panel test, which could serve as a useful supplementary tool for diagnosis and recurrence monitoring. This evidence concerns the gene CALCA and thyroid gland carcinoma.